Fundamental dimension Equity attribute | SHOPPeer $171.06▲+0.91% Cap $222.0BP/E 114.8x QuantScore60/100 | AMZNLeader $262.45▲+4.98% Cap $2.83TP/E 20.8x QuantScore71/100 | BABAPeer $99.64▼-2.14% Cap $247.9BP/E 21.5x QuantScore51/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
96/100 |
94/100 |
24/100 |
Valuation Multiples, PEG & DCF upside | 0/100 | 67/100 | 89/100 |
Health Piotroski, Altman Z, leverage & liquidity | 96/100 | 67/100 | 38/100 |
Growth Revenue / earnings growth & margins | 65/100 | 52/100 | 21/100 |
Sentiment Analyst ratings, targets & revisions | 45/100 | 73/100 | 81/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 114.8x | 20.8x | 21.5x |
Forward P/E (next FY) | 90.2x | 20.5x | 2.3x |
EV / EBITDA (TTM) | 92.1x | 11.7x | 11.4x |
Price / Sales | 16.7x | 3.6x | 1.6x |
Price / Free Cash Flow | 94.4x | -243.5x | -21.0x |
PEG ratio | -6.49 | 0.24 | -0.42 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 7 / 9 | 6 / 9 | 4 / 9 |
Altman Z-Score | 76.25 (Safe) | 4.67 (Safe) | 2.50 (Grey) |
Total debt / equity | 0.01 | 0.40 | 0.25 |
Quick ratio | 5.4x | 0.9x | 1.4x |
Interest coverage | — | 28.1x | 4.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +30.1% | +12.4% | +2.7% |
Net income growth YoY | -39.0% | +31.1% | -20.4% |
Gross margin (TTM) | 47.8% | 50.8% | 38.1% |
Operating margin (FY) | 12.7% | 11.2% | 5.8% |
FCF margin (FY) | 17.4% | 1.1% | -5.0% |
5. Trailing price performancePrice change over period |
1M return | +33.1% | +3.4% | -10.1% |
3M return | +38.4% | +6.2% | -12.6% |
6M return | +30.4% | +4.7% | -24.3% |
Year to date | +6.3% | +13.7% | -32.0% |
1Y return | +3.9% | +21.2% | -42.0% |
3Y return | +230.0% | +104.4% | +23.8% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $19.45 -88.6% premium | $48.00 -81.7% premium | $127.14 +27.6% upside |
Wall Street consensus target | $174.58 +2.1% · range $130.00–$210.00 | $328.90 +25.3% · range $200.00–$390.00 | $182.00 +82.7% · range $160.00–$209.00 |
Consensus stance | 67% Buy28% Hold5% Sell | 89% Buy10% Hold1% Sell | 86% Buy12% Hold2% Sell |